: iStockAnalyst.com Symbols Feed

FDA Calendar Updates: Former Extreme Trade Transcept Pharma (NASDAQ:TSPT) Surges On Deal

Mon, 03 Aug 2009 16:56:01 GMT

Below is a summary of updates to the BioMedReports.com FDA Calendar, which includes a database of 297 entries as of 8/3/09.. The calendar was originally created by Mike Havrilla to track companies with pending new drug, biological agent, or medical device new product decisions at the FDA. With the launch of BioMedReports.com, the FDA Calendar has expanded to include the following categories: pending new submissions to the FDA (e.g. NDA, ANDA, BLA, 510k, PMA, sNDA, sBLA filings), pending complete (...)[More...]

FDA Calendar Updates: BVX, HEB, HGSI, ONXX, SGP, ARDM, CBRX, MDT, Takeda

Thu, 23 Jul 2009 15:48:00 GMT

Below is a summary of updates to the BioMedReports.com FDA Calendar, which includes a database of 273 entries as of 7/22/09. The calendar was originally created by Mike Havrilla to track companies with pending new drug, biological agent, or medical device new product decisions at the FDA. With the launch of BioMedReports.com, the FDA Calendar has expanded to include the following categories: pending new submissions to the FDA (e.g. NDA, BLA, 510k, PMA, sNDA, sBLA filings), pending complete respo (...)[More...]

The Future For US Auto Stocks

Tue, 11 Nov 2008 14:31:00 GMT

There have been some pretty negative news surrounding the big three US auto manufacturers this year. Recently GM and Ford reported continuing large losses, triggered by a decrease in the demand for cars nationwide. The demand for cars, which typically is highly cyclical in nature, is lower because of the low consumer confidence in the economy as well as the difficulty that car buyers have in obtaining credit financing to purchase new vehicles. As a result of these events Detroit manufacturers’ stock prices have taken a large hit this year with GM losing 82% in 2008 while Ford stock lost only 70% during the same period of time. GM eliminated its dividend payment in July 2008 in order to boost its liquidity. The company has taken other measures to bolster its cash situation by selling off assets. Ford eliminated its dividend payments back in 2006. These two stocks should have been out of any dividend portfolio after the cuts, as every dividend investor knows that[More...]

Natural Gas and Oil Drive Higher

Mon, 12 May 2008 14:42:25 GMT

Natural gas advanced as crude oil surged to a record and the euro climbed against the U.S. dollar.[More...]

Investing in Biotechnology: One Market Is Always a Bull Market

Thu, 21 Feb 2008 20:31:56 GMT

It’s getting tougher and tougher to find safety. The tech sector is getting hit. Formerly high flying overseas are giving back some of their handsome gains. Even with oil prices hitting $100 a barrel again yesterday, the entire oil sector is off about 10% for the year.The bears have had their way. And, frankly, there aren’t too many drivers out there to help get things turned around. However, that doesn’t mean there aren’t opportunities; they’re just getting tougher to find.But as all of us have learned the hard way, if you’re not looking in the right place it can be almost impossible to find winners. That’s why today we’ll turn our attention to a sector that didn’t just survive every recession in the U.S. over the past two decades… it handsomely outperformed the major indexes.There have only been two recessions in the past 20 years, according to the National Bureau[More...]

Bovie Medical Corporation Announces FDA 510(K) Clearance to Market Laparoscopic Device for Solid Organ Resection; Submits to FDA 510(K) Application for Resistick II Coated Electrodes

Tue, 13 Oct 2009 17:07:00 GMT

Bovie Medical Corporation (the "Company") (NYSE-AMEX Symbol: BVX), a manufacturer and marketer of electrosurgical products, today announced the Company has received 510(k) clearance from the Food and Drug Administration (FDA) to market its laparoscopic SEER device for cutting and coagulating soft tissue.
The laparoscopic SEER is a line extension of the Saline Enhance Electrosurgical Resection (SEER) device that Bovie launched earlier this year and will address the kidney resection (partial Nephrectomies) market.
The laparoscopic SEER allows the surgeon to dissect and achieve coagulation with a single device resulting in less instrument utilization and fewer instrument changes in a minimally invasive approach.

[More...]

Bovie Medical Corporation Announces FDA 510(k) Clearance to Market Its J-Plasma Electrosurgical Generator and Handpiece

Tue, 11 Aug 2009 10:59:00 GMT

Bovie Medical Corporation (the “Company”) (NYSE-AMEX Symbol: BVX), a manufacturer and marketer of electrosurgical products, today announced the Company has received 510(k) clearance from the Food and Drug Administration (FDA) to market its J-Plasma ICON GS electrosurgical generator and handpiece.[More...]

Bovie Medical Corporation Announces Second Quarter Financial Results

Mon, 10 Aug 2009 11:46:00 GMT

Bovie Medical Corporation (the "Company") (NYSE Amex: BVX), a
J-plasma system (ICON GS Electrosurgical generator and handpiece).
Laparoscopic SEER device for solid organ resection.

[More...]

Bovie Medical Corporation Announces 510K Submissions to the FDA for Its VS Electrosurgical Generator

Mon, 03 Aug 2009 12:05:00 GMT

Bovie Medical Corporation (the "Company") (NYSE-AMEX Symbol: BVX), a manufacturer and marketer of electrosurgical products, today announced a 510K submission to the Food & Drug Administration seeking pre-market clearance for Bovie's ICON VS electrosurgical generator.
The generator has been designed to work with Bovie's Seal-N-Cut line of vessel sealing instruments providing both monopolar and bipolar energy options to the surgeon.
The fully digital ICON VS generator has a user friendly interface allowing the surgeon flexibility to choose the type of effect desired.

[More...]

Bovie Medical Corporation Announces 510K Submissions to the FDA for Its Seal-N-Cut™ Vessel Sealing Instruments

Wed, 22 Jul 2009 10:56:00 GMT

Bovie Medical Corporation (the “Company”) (NYSE-AMEX Symbol: BVX), a manufacturer and marketer of electrosurgical products, today announced a 510K submission to the Food & Drug Administration seeking pre-market clearance for Bovie’s Polarian Seal-N-Cut™ vessel sealing line of hybrid monopolar and bipolar forceps.[More...]

Bovie Medical Corporation Announces 510K Submission to the FDA for Its BOSS Soft Tissue Coagulation Device

Fri, 17 Jul 2009 10:57:00 GMT

Bovie Medical Corporation (the “Company”) (NYSE-AMEX Symbol: BVX), a manufacturer and marketer of electrosurgical products, today announced a 510K submission to the FDA seeking pre-market clearance for Bovie’s BOSS for surgical applications where soft tissue bipolar coagulation is desired. The BOSS is the latest generation device based on Bovie’s saline enhanced sintered steel technology.[More...]

Bovie Medical Corp. Selected to Be Included in the Russell 2000®, Russell 3000® and Russell Global Indexes

Mon, 22 Jun 2009 11:03:00 GMT

Bovie Medical Corporation (the “Company”) (NYSE-AMEX Symbol: BVX), a manufacturer and marketer of electrosurgical products, today announced it was selected to be part of the Russell 2000®, Russell 3000® and Russell Global Indexes when the Russell Investment Group reconstitutes its family of U.S. indexes on June 26th, according to a preliminary list of additions posted Friday, June 19th on www.russell.com.[More...]

Bovie Medical Corporation Announces FDA Submission of Laparoscopic Device for Solid Organ Resection

Tue, 19 May 2009 10:57:00 GMT

Bovie Medical Corporation (the “Company”) (NYSE-AMEX Symbol: BVX), a manufacturer and marketer of electrosurgical products, today announced a 510K submission to the FDA seeking pre-market clearance for a laparoscopic SEER device for solid organ resection. The laparoscopic SEER is a line extension of the Saline Enhance Electrosurgical Resection (SEER) device that Bovie launched earlier this year and will address the growing market of minimally invasive liver resection.[More...]

Bovie Medical Corporation Announces First Quarter Financial Results; Record First Quarter Revenues

Fri, 08 May 2009 11:50:00 GMT

Bovie Medical Corporation (the "Company") (NYSE Amex: BVX), a
its financial results for the first quarter ended March 31, 2009.
First quarter revenues increased 8.1% to a first quarter record $7.2

[More...]

Bovie Medical Corporation Announces New Director to Board

Fri, 24 Apr 2009 10:56:00 GMT

Bovie Medical Corporation (the “Company”) (NYSE-AMEX Symbol: BVX), a manufacturer and marketer of electrosurgical products, today announced Dr. Peter Pardoll, a board certified gastroenterologist, has been elected to Bovie’s board of directors. Dr. Pardoll succeeds Randy Rossi who resigned in March 2009.[More...]